Fluoropharma Medical Ownership
FPMI Stock | USD 0.0001 0.00 0.00% |
Fluoropharma |
Fluoropharma Pink Sheet Ownership Analysis
The company recorded a loss per share of 0.08. Fluoropharma Medical had not issued any dividends in recent years. FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey. Fluoropharma Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.The quote for Fluoropharma Medical is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Fluoropharma Medical call Thomas Tulip at 973-744-1565 or check out https://www.fluoropharma.com.Fluoropharma Medical Outstanding Bonds
Fluoropharma Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Fluoropharma Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Fluoropharma bonds can be classified according to their maturity, which is the date when Fluoropharma Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
MGM Resorts International Corp BondUS552953CD18 | View | |
Valero Energy Partners Corp BondUS91914JAA07 | View |
Currently Active Assets on Macroaxis
Other Information on Investing in Fluoropharma Pink Sheet
Fluoropharma Medical financial ratios help investors to determine whether Fluoropharma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fluoropharma with respect to the benefits of owning Fluoropharma Medical security.